Skip to main content
. 2015 Jul 7;33(4):216–226. doi: 10.1111/1755-5922.12128

Figure 7.

Figure 7

Markers of cardiac health following SG1002 treatment in heart failure subjects. (A) Fold change in the stress responsive polypeptide, BNP. Circulating BNP concentrations were measure at baseline, day 7 (completion of 200 mg BID), day 14 (400 mg BID), and day 21 (800 mg BID). (B) Relative reduced (GSH) and oxidized (GSSG) glutathione levels in RBCs at baseline, after 7 days of 200 mg BID (day 7), after 7 days of 400 mg BID (day 14), and after 7 days of 800 mg BID (day 21). Values are expressed as mean ± SEM.